◼ Archived Business 🔮 Newsylist predicts: still trending tomorrow low confidence — graded ✗ wrong

EyePoint Stock Craters 69% After Drug Trial Failure. It May Be an Overreaction.

Name: Trend velocity series: EyePoint Stock Craters 69% After Drug Trial Failure. It May Be an Overreaction.
Creator: Newsylist

2sources

2articles

1velocity

+0%since first seen

35d agofirst detected

Text:

Momentum

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📊 AUDIENCE & LONGEVITY PULSE

Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.

▲ Peaking Business

10 sources 11 articles v 9 22m ago

↓ Cooling Business

9 sources 9 articles v 7 22m ago

↑ Rising Business

11 sources 11 articles v 9 22m ago

▲ Peaking Business

9 sources 9 articles v 7 2h ago

↑ Rising Business

11 sources 12 articles v 10 2h ago

↓ Cooling Business 🔮 holds

10 sources 10 articles v 8 11h ago